Graphene 3D Lab Inc. Announces Name Change to G6 Materials Corp.
Graphene 3D Lab Inc. announces that on January 23, 2020, the Company will be changing its name to G6 Materials...
Sona Announces Conversion of Notes Payable
Sona Nanotech Inc. is converting notes payable of $95,000 and accrued interest of $67,322 owed to certain non-arm's length note...
Sona Nanotech Appoints New Director
Sona Nanotech Inc. (CSE:SONA) is pleased to announce the appointment of Mr. Jim Megann to the Company's Board of Directors.
Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors
Cardiol Therapeutics Inc. is pleased to announce the appointment of Mr. Colin Stott to its Board of Directors, effective immediately.
Dotz Nano Secures AU$3 Million Share Placement
Targeting manufacturing and oil & gas industries, Dotz plans to commercialise its carbon-based verification systems.
Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency
Cardiol Therapeutics Inc. commented on Purisys, LLC's news release issued on November 21st.
Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100
Cardiol Therapeutics Inc. is pleased to announce the formation of the Clinical Steering Committee for a Phase 2 international trial.